SINGLE-CELL IMMUNOMETABOLISM REVEALS A NOVEL PROGNOSTIC BIOMARKER IN ACUTE MYELOID LEUKEMIA AND UNCOVERS THE METABOLIC ROLE OF EXTRACELLULAR VESICLES

EHA Library, Dorian Forte, 4160511

INTEGRATIVE SYSTEMS BIOLOGY APPROACH UTILIZING TRANSCRIPTOMIC AND MUTATIONAL PROFILES TO UNVEIL PROGNOSIS-ASSOCIATED MOLECULAR PATHWAYS IN ACUTE MYELOID LEUKEMIA

EHA Library, Xiaoxue Wang, 4160512

INTERLEUKIN-8 IMPEDES MEGAKARYOCYTES PROPLATELET FORMATION VIA CXCR1/2-P38-NF-E2 SIGNAL AXIS LEADING TO THROMBOCYTOPENIA IN ACUTE MYELOID LEUKEMIA

EHA Library, Jing-li Han, 4160513

WHOLE GENOME SEQUENCING REVEALS MULTI-DIMENSIONAL GENETIC ABERRATIONS AND CONTRIBUTES SIGNIFICANTLY TO ELN 2022 RISK STRATIFICATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Guangxin Peng, 4160517

RAB37 ORCHESTRATES THE SREBP/SCD AXIS TO MODULATE LIPID METABOLISM AND DRIVE FERROPTOSIS RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Jishi Wang, 4160518

EXPLOITING TARGETED INHIBITION OF MASTL KINASE AS A NEW THERAPEUTIC TARGET FOR ACUTE MYELOID LEUKEMIA

EHA Library, Sandra M Martin-Guerrero, 4160522

RIPK3 INDUCES APOPTOSIS IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA CELLS VIA REGULATION OF MFN2-MEDIATED MITOCHONDRIAL FUSION

EHA Library, yan zhang, 4160523

ADVANCING NK CELL IMMUNOTHERAPY IN AML AND OVERCOMING CYTOKINE-DRIVEN ADAPTIVE RESISTANCE

EHA Library, Monika Sponheimer, 4160525

MOLECULAR CHARACTERISTICS OF AML DEFINED BY DIFFERENTIATION

EHA Library, Christoph Kornauth, 4160526

FROM XENOGRAFT TO PATIENT: THE IMPACT OF SURFACE MARKERS ON AML EXTRAMEDULLARY INVASION

EHA Library, Matteo Caridi, 4160527

VENETOCLAX INDUCES MITOCHONDRIAL APOPTOSIS AND AUTOPHAGY TO OVERCOME ARSENIC TRIOXIDE RESISTANCE IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Syed Hasan, 4160528

ANTI-LEUKEMIC ACTIVITY OF MITOTIC CHECKPOINT INHIBITOR BAL0891 AS MONOTHERAPY AND IN COMBINATION WITH TARGETED AGENTS

EHA Library, Mi Ji Choi, 4160531

CHARACTERISTICS AND PROGNOSTIC IMPACT OF IDH MUTATIONS IN A REAL-LIFE COHORT OF 217 PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Antonella Cucca, 4160532

SPHINGOSINE-1-PHOSPHATE (S1P) MODULATOR FTY720 SYNERGIZES WITH VENETOCLAX IN AML THROUGH MTOR PATHWAY SUPPRESSION, MITOCHONDRIAL DAMAGE, AND LYSOSOMAL STRESS INDUCTION

EHA Library, Katia Beider, 4160533

THZ1-INDUCED DNA DAMAGE TRIGGERS BOTH P53-DEPENDENT AND INDEPENDENT APOPTOSIS IN AML

EHA Library, Weidong Ding, 4160534

HOW AML MIGHT EXPLOIT RNA GRANULES FOR STRESS SHELTER, MORE THAN OTHER CANCERS.

EHA Library, Alessandro Pilli, 4160535

ABNORMAL DNA DAMAGE RESPONSE SUGGESTS NOVEL FINGERPRINT OF RELAPSE IN ACUTE MONOCYTIC LEUKEMIA POST TRANSPLANTATION

EHA Library, Yukun FENG, 4160538

A NEW ALGORITHM FOR HARMONIZING LARGE-SCALE RNA-SEQ INTEGRATION IN AML: ENABLING PLATFORM FOR DEEP ANALYSIS AND DISCOVERY

EHA Library, Matteo Caridi, 4160539

PAEONIFLORIN TARGETING M6A RNA METHYLATION IMPROVES BNIP3 ASSOCIATE MITOPHAGY IN DOXORUBICIN-INDUCED MYOCARDIAL CARDIOTOXICITY

EHA Library, Xing Cui, 4160541

LIMS1 REGULATES ACUTE MYELOID LEUKEMIA INITIATION THROUGH CELL-ADHESION INTERACTIONS AND MIGRATION OF LEUKEMIC STEM CELLS

EHA Library, Talia Velasco-Hernandez, 4160542

PATIENTS WITH RELAPSED OR REFRACTORY (R/R) NUCLEOPHOSMIN 1-MUTATED (NPM1M) ACUTE MYELOID LEUKEMIA (AML): UPDATED RESULTS FROM THE PHASE 2 AUGMENT-101 STUDY

EHA Library, Martha L Arellano, 4160543

VALIDATION OF THE EUROPEAN LEUKEMIANET 2024 RISK STRATIFICATION IN PATIENTS WITH NEWLY-DIAGNOSED AML TREATED WITH HMA+VEN: REAL-WORLD DATA BASED ON THE STUDY ALLIANCE LEUKEMIA AML REGISTRY

EHA Library, Lydia Kretschmer, 4160544

HYPOMETHYLANTS IN MONOTHERAPY OR COMBINED WITH VENETOCLAX: REAL-LIFE EXPERIENCE IN 1964 PATIENTS REPORTED TO THE PETHEMA-GPLA REGISTRY

EHA Library, Eliana Aguiar, 4160545

PROGNOSTIC VALUE OF MOLECULAR MEASURABLE RESIDUAL DISEASE MONITORED BY DIGITAL PCR BEFORE AND AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN TP53-MUTATED AML/MDS COHORT: A TROPHY STUDY

EHA Library, Yanmin Zhao, 4160548

UPDATED RESULTS AND LONGER FOLLOW-UP FROM THE AUGMENT-101 PHASE 2 STUDY OF REVUMENIB IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) KMT2AR ACUTE LEUKEMIA

EHA Library, Ibrahim Aldoss, 4160549

PHASE II STUDY OF CLADRIBINE WITH LOW DOSE CYTARABINE AND VENETOCLAX ALTERNATING WITH AZACYTIDINE AND VENETOCLAX FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Alex Bataller, 4160556

SECOND INDUCTION CYCLE BEFORE ALLOHSCT DOES NOT IMPROVE SURVIVAL IN ADVERSE-RISK AML PATIENTS IN COMPLETE REMISSION AFTER FIRST INDUCTION

EHA Library, Lukas Haaksma, 4160557

HIGH EFFICIENCY OF SALVAGE THERAPY COMBINING 7 DAYS VENETOCLAX AND G-CSF, FLUDARABINE, HIGH-DOSE CYTARABINE, AND MITOXANTRONE FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED/REFRACTORY ACUTE MYELOBLASTIC LEUKEMIA

EHA Library, Ahmad Ibrahim, 4160558

PRIMARY RESULTS STIMULUS-AML1: A LARGE, INTERNATIONAL, PHASE II STUDY OF SABATOLIMAB COMBINED WITH AZACITIDINE AND VENETOCLAX AS FRONTLINE THERAPY FOR UNFIT ACUTE MYELOID LEUKEMIA (AML) PATIENTS (PTS)

EHA Library, Amer M. Zeidan, 4160559

DECITABINE COMBINED WITH HAAG FOR NEWLY DIAGNOSED PARENTS WITH POOR-RISK ACUTE MYELOID LEUKEMIA: A PROSPECTIVE, PHASE 3, RANDOMIZED, MULTI-CENTER STUDY

EHA Library, Xiao-Wen Tang, 4160564

IMPACT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION ON PROGNOSIS IN ACUTE MYELOID LEUKEMIA WITH DIFFERENT CEBPA MUTATION SUBTYPES

EHA Library, Xiaohui Zhang, 4160565

PROGNOSTIC VALUE OF IDH1 AND IDH2 MUTATIONS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA

EHA Library, Guillermo Ramil, 4160573

THE IMPACT OF ALLOGENIC STEM CELL TRANSPLANTATION ON NPM1MUTFLT3MUT AML PATIENTS IN FIRST REMISSION DEPENDS ON MRD STATUS AFTER CONSOLIDATION CHEMOTHERAPY: A RETROSPECTIVE MULTICENTRIC ITALIAN STUDY

EHA Library, Sara Consolo, 4160574

PROGNOSTIC SIGNIFICANCE OF RUNX1 MUTATIONS IN ACUTE MYELOID LEUKEMIA: IMPACT OF CONCURRENT GENETIC ALTERATIONS ON SURVIVAL

EHA Library, Hsin-Yu Lu, 4160575

A NOVEL RANDOM SURVIVAL FOREST MODEL FOR ADULT NPM1-MUTATED ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Yiyi Yao, 4160576

COMPARABLE SURVIVAL OUTCOMES FOR SECONDARY AND DE NOVO ACUTE MYELOID LEUKEMIA AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Kehan Zhang, 4160579

IMPACT OF TYROSINE KINASE INHIBITORS ON OUTCOMES IN PHILADELPHIA CHROMOSOME-POSITIVE MIXED PHENOTYPE ACUTE LEUKEMIA: DATA FROM THE PETHEMA/PALG REGISTRY

EHA Library, Marta Sobas, 4160580

GENETIC ABNORMALITIES PREDICT OUTCOMES IN ACUTE MYELOID LEUKEMIA PATIENTS WITH CEBPA IN-FRAME MUTATIONS

EHA Library, Shunjie Yu, 4160581

NGS VS DIGITAL PCR FOR MRD MONITORING IN ACUTE MYELOID LEUKEMIA: A COMPARATIVE STUDY

EHA Library, Guillermo Ramil, 4160582

LONG TERM SURVIVAL AND VACCINE-INDUCED IMMUNE RESPONSES ARE COMPARABLE BETWEEN NPM1 MUTATED VS NPM1 WILD TYPE AML PATIENTS AFTER IMMUNOTHERAPY WITH VIDIDENCEL

EHA Library, Arjan van de Loosdrecht, 4160583

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN PARTIALLY OVERCOME THE ADVERSE PROGNOSTIC IMPACT OF TP53 ALTERATIONS IN AML PATIENTS.

EHA Library, Dan Feng, 4160587

EVALUATION OF THE 2022 ELN RISK CLASSIFICATION IN ACUTE MYELOID LEUKEMIA PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: IDENTIFICATION OF A VERY POOR PROGNOSIS SUBGROUP

EHA Library, Huixian Wu, 4160588

COMPARING OUTCOMES OF PATIENTS WITH DE NOVO AND SECONDARY AML, TREATED FRONTLINE WITH VENETOCLAX AND HYPOMETHYLATING AGENTS: A MULTICENTER RETROSPECTIVE STUDY.

EHA Library, Ilaria Tanasi, 4160589

A PHASE I STUDY OF VENETOCLAX, AZACITIDINE, AND MITOXANTRONE HYDROCHLORIDE LIPOSOME IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Wenxiang Ren, 4160591

ENHANCED PROGNOSIS OF DMCEBPABZIP-INF MUTATIONS IN ACUTE MYELOID LEUKEMIA: INSIGHTS FROM A MULTI-CENTER CHINESE COHORT

EHA Library, Guanghui Chang, 4160593

COVALENT FLT3 INHIBITOR BMF-500 IN RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIA (AL): PRELIMINARY PHASE 1 DATA FROM THE COVALENT-103 STUDY (NCT05918692)

EHA Library, Farhad Ravandi-Kashani, 4160595

TREATMENT AND SURVIVAL OF MIXED PHENOTYPE ACUTE LEUKAEMIA - A POPULATION-BASED COHORT

EHA Library, Lisa-Maj Christensen, 4160597

TREATMENT INTENSITY IS ASSOCIATED WITH DISTINCT LONGITUDINAL TRAJECTORIES OF FRAILTY IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Victoria Ling, 4160598

THE EFFICACY AND PROGNOSTIC EVALUATION OF BTG1 IN HYPOMETHYLATING AGENTS TREATMENT FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Shuai Su, 4160599

VENETOCLAX PLUS MITOXANTRONE HYDROCHLORIDE LIPOSOME AND AZACITIDINE AS FIRST-LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Weiwei Qin, 4160600

CD4+ T CELLS, GRANZYME B+ NK, MZ B CELLS AND DIFFERENTIATED/SENESCENT CD4+CD28- T CELLS AFTER INDUCTION TREATMENT PREDICT AML PATIENT'S OUTCOME

EHA Library, Xin Huang, 4160602

THE RESULTS OF TREATMENT OF ACUTE LEUKEMIA DIAGNOSED DURING PREGNANCY

EHA Library, Vera Troitskaya, 4160603

FEASIBILITY AND SAFETY OF OUTPATIENT CONSOLIDATION CHEMOTHERAPY IN ACUTE MYELOID LEUKEMIA

EHA Library, Laura Curras Sanchez, 4160606

EFFICACY AND SAFETY OF VAC (VENETOCLAX, AZACITIDINE, CHIDAMIDE) REINDUCTION TREATMENT FOR UNFIT ACUTE MYELOID LEUKEMIA PATIENTS FAILED TO RESPOND TO ONE CYCLE OF VA INDUCTION

EHA Library, Shengli Xue, 4160607

HPK1 INHIBITOR BGB-15025 INDUCES APOPTOSIS IN AML CELLS THROUGH CELL CYCLE PATHWAY AND MAPK/ERK SIGNALING AXIS.

EHA Library, Shiyu Yang, 4160510

DEEP TARGETED SEQUENCING TO MONITOR MEASURABLE RESIDUAL DISEASE AND CHIMERISM IN MIELOID MALIGANCIES AFTER ALLOGENIC STEM CELL TRANSPLANT

EHA Library, Irene Zamanillo, 4160514

SELECTIVE THERAPEUTIC TARGETING ON MNX1-DRIVEN PROGRAMS IN INFANT AML

EHA Library, Ylenia Cicirò, 4160515

AVPR2-DRIVEN NEUROHYPOPHYSEAL DYSFUNCTION IN ADVERSE-RISK CYTOGENETIC AML: MECHANISTIC INSIGHTS AND SURVIVAL IMPLICATIONS

EHA Library, Diyaer Abuduaini, 4160516

GUICAOBAIDU DECOCTION ALLEVIATES DOXORUBICIN-INDUCED MYOCARDIAL CARDIOTOXICITY VIA AMELIORATION OF TRDMT1/BNIP3 MEDIATED MITOPHAGY IN MICE

EHA Library, Xing Cui, 4160519

(LEUKEMIA-SPECIFC) B-CELLS IN AML PATIENTS CAN BE INDUCED BY IMMUNE MODULATORY THERAPY (KIT M: GM-CSF AND PGE-1) AND CONTRIBUTE TO IMPROVE ANTILEUKEMIC RESPONSE

EHA Library, Helga Schmetzer, 4160520

TRANSCRIPTOMIC AND CELLULAR DECONVOLUTION ANALYSIS REVEALS DISTINCT PROFILES ASSOCIATED WITH CYTARABINE RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Alba Mora, 4160521

STUDY ON THE SYNTHETIC LETHAL MECHANISM OF SELECTIVE KILLING OF ALDH2 DEFICIENT ACUTE MYELOID LEUKEMIA CELLS BY INHIBITING BRIP1

EHA Library, Jishi Wang, 4160524

DELETERIOUS ROLE OF BYSTANDER CD8 T CELLS PRODUCING GRANZYME K IN ACUTE MYELOID LEUKEMIA PROGRESSION

EHA Library, Yannick Simoni, 4160529

PROGNOSTIC IMPACT OF FLT3-ITD LENGTH AND CLONAL PERSISTENCE IN MYELOID NEOPLASMS

EHA Library, Suresh Balasubramanian, 4160530

ACUTE MYELOID LEUKEMIA WITH 7Q DELETION: INCIDENCE, PROGNOSTIC, AND IMPACT ON RESPONSE TO BORTEZOMIB IN COMBINATION WITH AZACITIDINE OF EZH2 ALTERATIONS.

EHA Library, Iván Martín, 4160536

EXPLORATION OF MUTATIONAL PATTERNS AND THEIR IMPACT ON THE IMMUNE MICROENVIRONMENT IN ACUTE MYELOID LEUKEMIA THROUGH IN SILICO ANALYSES

EHA Library, Allana Carvalho, 4160537

REGULATORY T CELL-PREDOMINANT TUMOR MICROENVIRONMENT (TME) PREDICTS POOR OUTCOMES IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN).

EHA Library, Claudia Tobar Cabrera, 4160540

RISK STRATIFICATION OF NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX IN COMBINATION WITH INTENSIVE CHEMOTHERAPY

EHA Library, Wei-Ying Jen, 4160546

A PHASE IB/2 TRIAL OF AN ALL-ORAL „TRIPLET” REGIMEN FOR IDH-MUTATED MYELOID MALIGNANCIES: DECITABINE/CEDAZURIDINE AND VENETOCLAX IN COMBINATION WITH IVOSIDENIB/ENASIDENIB

EHA Library, Jennifer Marvin-Peek, 4160547

CLINICAL FEATURES, TREATMENT PATTERNS AND OUTCOMES IN 405 ADULT PATIENTS WITH MIXED PHENOTYPE ACUTE LEUKEMIA: A STUDY FROM THE PETHEMA AND PALG GROUPS

EHA Library, Marta Sobas, 4160550

IS MEASURABLE RESIDUAL DISEASE (MRD) ASSESSMENT BY MULTIPARAMETER FLOW CYTOMETRY (MFC) A VALID EARLY ENDPOINT OF TREATMENT EFFICACY IN ACUTE MYELOID LEUKEMIA (AML): A PETHEMA STUDY IN 2,819 PATIENTS

EHA Library, Bruno Paiva, 4160551

VENETOCLAX PLUS HIGH-DOSE CYTARABINE AND MITOXANTRONE (HAM-VEN) IN RELAPSED/REFRACTORY AML: A REAL-WORLD ANALYSIS FROM SAL AND AMLCG STUDY CENTERS

EHA Library, Andrew Berdel, 4160552

UNVEILING DISTINCT MOLECULAR AND PROGNOSTIC FEATURES: AN RNA-BASED PROGNOSTIC MODEL FOR INFANT ACUTE MYELOID LEUKEMIA

EHA Library, YU TAO, 4160553

RESULTS FROM A CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 (ORAL AZACITIDINE) AND VENETOCLAX FOR NEWLY DIAGNOSED AND RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Maria Amaya, 4160554

THE PROGNOSTIC IMPACT OF TRISOMY 8 IN ACUTE MYELOID LEUKEMIA

EHA Library, Daniel Tuyet Kristensen, 4160555

CIRCULATING TUMOR DNA BETTER DISCRIMINATES TRUE MRD POSITIVITY FOR THE RISK STRATIFICATION OF CHILDHOOD ACUTE MYELOID LEUKEMIA

EHA Library, Lipeng Liu, 4160560

HIGH REMISSION RATES IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA WITH QHRD107 (CDK9 INHIBITOR), VENETOCLAX, AND AZACITIDINE COMBINATION THERAPY (107VA REGIMEN): PRELIMINARY RESULTS FROM A PHASE 2A STUDY

EHA Library, Yunxiang Zhang, 4160561

OUTCOMES IN PATIENTS YOUNGER THAN 50 YEARS OLD WITH TREATMENT-NAÏVE BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM TREATED WITH TAGRAXOFUSP: SUBANALYSIS OF A PHASE 1/2 TRIAL

EHA Library, Anthony Stein, 4160562

CLINICAL UTILITY OF METAGENOMIC NEXT-GENERATION SEQUENCING IN FEBRILE NEUTROPENIA OF HEMATOLOGICAL MALIGNANCY: A RETROSPECTIVE COMPARISON OF DIAGNOSTIC PERFORMANCE AND THERAPEUTIC IMPACT

EHA Library, Liping Dou, 4160563

IMPACT OF DAY 14 MEASURABLE RESIDUAL DISEASE IN NEWLY DIAGNOSED UNFIT ACUTE MYELOID LEUKEMIA PATIENTS DURING THE AZACITIDINE PLUS VENETOCLAX REGIMEN AS THE INDUCTION THERAPY

EHA Library, Ying Lu, 4160567

RESPONSE RATES IN ACUTE MYELOID LEUKEMIA WITH SUSPECTED GERMLINE DDX41 MUTATIONS

EHA Library, Jesus D. Gonzalez-Lugo, 4160568

BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN): PROGNOSTIC FACTORS AND TREATMENT OUTCOMES IN 69 MAYO CLINIC PATIENTS

EHA Library, Erica Andres, 4160569

NUCLEOSIDE ANALOGUE-BASED INDUCTION (CLAG-M OR FLAGIDA) RESULTS IN HIGHER REMISSION RATES THAN STANDARD AML OR ALL-LIKE INTENSIVE INDUCTION REGIMENS IN MIXED PHENOTYPE ACUTE LEUKAEMIA. A STUDY FROM THE PETHEMA/PALG REGISTRIES.

EHA Library, Magdalena Karasek, 4160570

CONSTRUCTION OF A PROGNOSTIC MODEL FOR ACUTE MYELOID LEUKEMIA BASED ON FLOW CYTOMETRY IMMUNOPHENOTYPING USING MACHINE LEARNING METHODS.

EHA Library, Qing Ma, 4160571

OUTCOMES OF ADULT PATIENTS WITH NEWLY DIAGNOSED IDH-MUTATED ACUTE MYELOID LEUKEMIA RECEIVING INTENSIVE CHEMOTHERAPY PLUS VENETOCLAX

EHA Library, Jennifer Croden, 4160572

REVUMENIB ACTIVITY IN PATIENTS WITH ACUTE LEUKEMIA WITH NUP98R: RESULTS FROM THE AUGMENT-101 PHASE 1 STUDY

EHA Library, Ghayas Issa, 4160577

VENETOCLAX-AZACITIDINE PLUS IDARUBICIN IN OLDER AML PATIENTS: A PHASE II TRIAL EVALUATING FEASIBILITY AND EARLY OUTCOMES

EHA Library, Xinjie Chen, 4160578

REAL-WORLD PATTERNS AND OUTCOMES IN AML PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: DATA FROM THE PETHEMA REGISTRY

EHA Library, Laura Torres Miñana, 4160584

PRELIMINARY RESULTS FROM RIVER-81, A PHASE 2 STUDY OF RVU120+VEN IN PATIENTS WITH AML FAILING FIRST LINE VEN+HMA

EHA Library, Noemi Angelosanto, 4160585

MITOXANTRONE HYDROCHLORIDE LIPOSOME-BASED INDUCTION REGIMENS FOR UNTREATED DE NOVO ACUTE MYELOID LEUKEMIA: AN OPEN-LABEL, MULTICENTER, RANDOMIZED, MULTICOHORT STUDY

EHA Library, Shaowei Qiu, 4160586

REAL WORLD OUTCOMES OF ADULT PATIENTS WITH NUP98 GENE REARRANGED ACUTE MYELOID LEUKEMIA

EHA Library, Laura Torres Miñana, 4160590

OUTCOMES OF THE ACUTE MYELOID LEUKEMIA-DEFINING MECOM REARRANGEMENT DIFFER BASED ON BLAST COUNT AT DIAGNOSIS

EHA Library, Wei-Ying Jen, 4160592

PROGNOSTIC IMPACT OF EXTRAMEDULLARY DISEASE IN ACUTE MYELOID LEUKEMIA: A META-ANALYSIS

EHA Library, Yufan Lin, 4160594

TWICE WEEKLY LOW DOSE DECITABINE PLUS VENETOCLAX VERSUS AZACYTIDINE PLUS VENETOCLAX IN THE FRONTLINE TREATMENT OF ACUTE MYELOID LEUKEMIA, INELIGIBLE FOR INTENSIVE CHEMOTHERAPY

EHA Library, Ciprian Tomuleasa, 4160601

SAFETY AND EFFICACY OF LOW-DOSE VENETOCLAX PLUS VORICONAZOLE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA UNFIT FOR INTENSIVE CHEMOTHERAPY

EHA Library, zhangbiao long, 4160604

PERI-TRANSPLANT KMT2A-REARRANGED MRD DYNAMICS AS A PROGNOSTIC MARKER IN ADULT ACUTE MYELOID LEUKEMIA

EHA Library, Lulu Wang, 4160605

MEASURABLE MINIMAL RESIDUAL DISEASE BY AN ULTRA-SENSITIVE NGS METHOD TO EVALUATE THE RESPONSE IN ACUTE MYELOID LEUKEMIA, THE VENAQUI CLINICAL TRIAL

EHA Library, Rosa Maria Ayala Diaz, 4160608

TOWARDS THE USE OF ARTIFICIAL INTELLIGENCE MODELS IN THE ASSESSMENT OF ACUTE PROMYELOCYTIC LEUKEMIA - SYSTEMATIC REVIEW

EHA Library, Mihnea-Alexandru Găman, 4160609

VEN-BASED SCHEMES, ARE THEY BETTER THAN '3 + 7'?

EHA Library, Pedro Amorim Machado, 4160610

ALLOGENEIC TRANSPLANTATION VS. CHEMOTHERAPY AS CONSOLIDATION STRATEGIES IN OLDER ACUTE MYELOID LEUKEMIA PATIENTS AFTER FIRST COMPLETE REMISSION: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Cilomar Martins de Oliveira Filho, 4160611